Navigation Links
Tobacco use linked to worse outcomes in HPV-positive head and neck cancer, U-M study finds

ANN ARBOR, Mich. Patients with head and neck cancer linked to high risk human papillomavirus, or HPV, have worse outcomes if they are current or former tobacco users, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

High-risk HPVs are the same viruses that are associated with cancers of the uterine cervix.

The research suggests that current or former tobacco users may need a more aggressive treatment regimen than patients who have never used tobacco.

Past research shows that HPV-positive head and neck cancers tend to be more responsive to current treatments and these patients overall tend to have better outcomes than patients with HPV-negative tumors. However, the new study found that current tobacco users with HPV-positive tumors were five times more likely to have their cancer recur. Even former smokers had an increased risk of recurrence.

"Because the effect of HPV is so strong in giving a very good prognostic picture, we were surprised to find that smoking remained a huge issue, and it actually affected the outcome in patients who smoked," says senior study author Thomas Carey, Ph.D., professor of otolaryngology and pharmacology, and co-director of the Head and Neck Oncology Program at the U-M Comprehensive Cancer Center.

Results of the study appear in the Feb. 15 issue of Clinical Cancer Research.

The study looked at 124 patients with advanced oropharyngeal cancer, which is cancer of the tonsils or the base of the tongue. Most of these patients had HPV DNA in their tumors, which is consistent with HPV being a major factor in oropharyngeal cancer development. All 22 of the HPV-negative patients were tobacco users, and about two-thirds of the 102 HPV-positive patients were current or former tobacco users.

Of the HPV-positive patients who had never used tobacco, 6 percent had a recurrence of their cancer. Meanwhile, 19 percent of form

Contact: Nicole Fawcett
University of Michigan Health System

Page: 1 2

Related biology news :

1. Tobacco plant-made therapeutic thwarts West Nile virus
2. Tobacco plant thwarts caterpillar onslaught by opening flowers in the morning
3. Changing flowering times protect tobacco plants against insect herbivory
4. Engineered tobacco plants have more potential as a biofuel
5. Study confirms association between tobacco smoke and behavioral problems in children
6. Smokeless tobacco called moist snuff is contaminated with harmful substances
7. Exposure to lead, tobacco smoke raises risk of ADHD
8. Novel mechanism revealed for increasing recombinant protein yield in tobacco
9. Women more vulnerable to tobacco carcinogens, new results show
10. Tobacco makes medicine
11. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
Post Your Comments:
Related Image:
Tobacco use linked to worse outcomes in HPV-positive head and neck cancer, U-M study finds
(Date:9/28/2015)... According to a new market ... (Scanner & Others), Application (Access Control & Others), Industry ... Geography Global - Forecast to 2020", published by MarketsandMarkets, the ... Million by 2020, at a CAGR of 23.40% between ... data T ables and 66 Figures ...
(Date:9/24/2015)... September 24, 2015 ... 2015 Kerv ( ... lanserar idag världens första kontaktlösa betalningsring på ... 77 000 GBP för massproduktion via crowdfunding.  ... ) , Kerv-bärare kan göra ...
(Date:9/10/2015)... ATLANTA , Sept. 10, 2015 ... Cleveland Clinic Wellness to create an interactive, image-based ... self-service health and wellness kiosk.  The unique assessment ... Age"— a number that suggests an individual,s biological ... biometric values as measured by the kiosk. ...
Breaking Biology News(10 mins):
... The discovery by Uppsala University researchers of a previously ... ways brings new potential for early diagnosis of a ... the Web edition of the American journal Proceedings ... provide new knowledge of the cause of common diseases ...
... native fishes in the Pacific Northwest are threatened or ... are expended annually on researching their populations and on ... been directed toward to the impacts of habitat alteration, ... published in the March 2009 issue of BioScience ...
... Society for Clinical and Economic Aspects of Osteoporosis and ... scientific programme for the upcoming IOF WCO- ECCEO10, a ... May 5-8, 2010. Complete programme information, online ... . IOF WCO-ECCEO10 will offer ...
Cached Biology News:
(Date:10/7/2015)... ... ... Neil Riordan, PhD to Discuss Medicinal Effects of Mesenchymal Stem Cells and ... pm to 4:30 pm. , Dr. Riordan is one of the early pioneers and ... Co-Founder and Chief Science Officer of the Riordan-McKenna Institute of Regenerative Orthopedics ...
(Date:10/7/2015)... --  PDI , a leader in infection prevention products ... challenges across various healthcare settings, as well as guidelines ... tool is part of a larger effort to raise ... and lower healthcare-associated infections. ... how to use the right product, in the right ...
(Date:10/7/2015)... ... October 07, 2015 , ... Park Systems , ... Coatings to provide a comprehensive overview of the innovations in smart coatings using ... . This webinar will be given by Professor Roberto Advincula, professor with ...
(Date:10/6/2015)... ... October 06, 2015 , ... ... new microscope technology that could help surgeons work with a greater degree of ... as blood flow and cancerous tissue over real images of blood vessels and ...
Breaking Biology Technology:
... -- China,Biologic Products, Inc. (OTC Bulletin Board: CBPO) ... plasma-based pharmaceutical companies in the,People,s Republic of China ... "High-Purity Human Albumin," will be listed in the ... The National Torch Plan was organized and ...
... Feb. 13 Pharmacyclics, Inc.,(Nasdaq: PCYC ) today ... 2008. The net loss for the second quarter of fiscal ... net loss of $5.9 million,or $0.23 per share, in the ... Total operating expenses were $4.9 million in the second quarter ...
... -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" ... high-quality, pharmaceutical grade,glucose products in China, today reported ... ended December 31, 2008. , ... the second quarter,compared with the September quarter," said ...
Cached Biology Technology:
Synaptotagmin, phosphoSer309...
Sheep polyclonal to Staphylococcus DNase ( Abpromise for all tested applications). Antigen: Full length native protein (purified)....
Mouse anti-hepatitis delta virus Class: Antibody Product Group: Bacterial and Viral Antigen...
Allophycocyanin (APC) anti-human CD193 (CCR3, CKR3) 25 tests...
Biology Products: